SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
8-K	Report of unscheduled material events or corporate event	Jul 19, 2013	View HTML 0001193125-13-294906.pdf 0001193125-13-294906.rtf 0001193125-13-294906.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Jul 19, 2013	View HTML 0001193125-13-295848.pdf 0001193125-13-295848.rtf 0001193125-13-295848.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Jul 18, 2013	View HTML 0001193125-13-294448.pdf 0001193125-13-294448.rtf 0001193125-13-294448.xls
10-Q	Quarterly report which provides a continuing view of a company's financial position	May 14, 2013	View HTML 0001193125-13-219166.pdf 0001193125-13-219166.rtf 0001193125-13-219166.xls EX-101.INS - XBRL INSTANCE DOCUMENT
8-K	Report of unscheduled material events or corporate event	May 13, 2013	View HTML 0001193125-13-216656.pdf 0001193125-13-216656.rtf 0001193125-13-216656.xls
8-K	Report of unscheduled material events or corporate event	Mar 22, 2013	View HTML 0001193125-13-120940.pdf 0001193125-13-120940.rtf 0001193125-13-120940.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 14, 2013	View HTML 0001085146-13-000500.pdf 0001085146-13-000500.rtf 0001085146-13-000500.xls
10-Q	Quarterly report which provides a continuing view of a company's financial position	Feb 08, 2013	View HTML 0001193125-13-045326.pdf 0001193125-13-045326.rtf 0001193125-13-045326.xls EX-101.INS - XBRL INSTANCE DOCUMENT
8-K	Report of unscheduled material events or corporate event	Feb 06, 2013	View HTML 0001193125-13-041044.pdf 0001193125-13-041044.rtf 0001193125-13-041044.xls
EFFECT	EFFECT	Jan 23, 2013	View HTML 9999999995-13-000259.pdf 9999999995-13-000259.rtf

Data provided by Kaleidoscope.